Regulation of the pancreatic pro-endocrine gene neurogenin3

Jane C. Lee, Stewart B. Smith, Hirotaka Watada, Joseph Lin, David Scheel, Juehu Wang, Raghu Mirmira, Michael S. German

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Neurogenin3 (ngn3), a basic helix-loop-helix (bHLH) transcription factor, functions as a pro-endocrine factor in the developing pancreas: by itself, it is sufficient to force undifferentiated pancreatic epithelial cells to become islet cells. Because ngn3 expression determines which precursor cells will differentiate into islet cells, the signals that regulate ngn3 expression control islet cell formation. To investigate the factors that control ngn3 gene expression, we mapped the human and mouse ngn3 promoters and delineated transcriptionally active sequences within the human promoter. Surprisingly, the human ngn3 promoter drives transcription in all cell lines tested, including fibroblast cell lines. In contrast, in transgenic animals the promoter drives expression specifically in regions of ngn3 expression in the developing pancreas and gut; and the addition of distal sequences greatly enhances transgene expression. Within the distal enhancer, binding sites for several pancreatic transcription factors, including hepatocyte nuclear factor (HNF)-1 and HNF-3, form a tight cluster. HES1, an inhibitory bHLH factor activated by Notch signaling, binds to the proximal promoter and specifically blocks promoter activity. Together with previous genetic data, these results suggest a model in which the ngn3 gene is activated by the coordinated activities of several pancreatic transcription factors and inhibited by Notch signaling through HES1.

Original languageEnglish (US)
Pages (from-to)928-936
Number of pages9
JournalDiabetes
Volume50
Issue number5
StatePublished - 2001
Externally publishedYes

Fingerprint

Islets of Langerhans
Pancreas
Hepatocyte Nuclear Factor 1
Transcription Factors
Hepatocyte Nuclear Factors
Genes
Basic Helix-Loop-Helix Transcription Factors
Cell Line
Genetically Modified Animals
Transgenes
Fibroblasts
Epithelial Cells
Binding Sites
Gene Expression

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lee, J. C., Smith, S. B., Watada, H., Lin, J., Scheel, D., Wang, J., ... German, M. S. (2001). Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes, 50(5), 928-936.

Regulation of the pancreatic pro-endocrine gene neurogenin3. / Lee, Jane C.; Smith, Stewart B.; Watada, Hirotaka; Lin, Joseph; Scheel, David; Wang, Juehu; Mirmira, Raghu; German, Michael S.

In: Diabetes, Vol. 50, No. 5, 2001, p. 928-936.

Research output: Contribution to journalArticle

Lee, JC, Smith, SB, Watada, H, Lin, J, Scheel, D, Wang, J, Mirmira, R & German, MS 2001, 'Regulation of the pancreatic pro-endocrine gene neurogenin3', Diabetes, vol. 50, no. 5, pp. 928-936.
Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes. 2001;50(5):928-936.
Lee, Jane C. ; Smith, Stewart B. ; Watada, Hirotaka ; Lin, Joseph ; Scheel, David ; Wang, Juehu ; Mirmira, Raghu ; German, Michael S. / Regulation of the pancreatic pro-endocrine gene neurogenin3. In: Diabetes. 2001 ; Vol. 50, No. 5. pp. 928-936.
@article{2994535f503d443ab0764441d338b967,
title = "Regulation of the pancreatic pro-endocrine gene neurogenin3",
abstract = "Neurogenin3 (ngn3), a basic helix-loop-helix (bHLH) transcription factor, functions as a pro-endocrine factor in the developing pancreas: by itself, it is sufficient to force undifferentiated pancreatic epithelial cells to become islet cells. Because ngn3 expression determines which precursor cells will differentiate into islet cells, the signals that regulate ngn3 expression control islet cell formation. To investigate the factors that control ngn3 gene expression, we mapped the human and mouse ngn3 promoters and delineated transcriptionally active sequences within the human promoter. Surprisingly, the human ngn3 promoter drives transcription in all cell lines tested, including fibroblast cell lines. In contrast, in transgenic animals the promoter drives expression specifically in regions of ngn3 expression in the developing pancreas and gut; and the addition of distal sequences greatly enhances transgene expression. Within the distal enhancer, binding sites for several pancreatic transcription factors, including hepatocyte nuclear factor (HNF)-1 and HNF-3, form a tight cluster. HES1, an inhibitory bHLH factor activated by Notch signaling, binds to the proximal promoter and specifically blocks promoter activity. Together with previous genetic data, these results suggest a model in which the ngn3 gene is activated by the coordinated activities of several pancreatic transcription factors and inhibited by Notch signaling through HES1.",
author = "Lee, {Jane C.} and Smith, {Stewart B.} and Hirotaka Watada and Joseph Lin and David Scheel and Juehu Wang and Raghu Mirmira and German, {Michael S.}",
year = "2001",
language = "English (US)",
volume = "50",
pages = "928--936",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Regulation of the pancreatic pro-endocrine gene neurogenin3

AU - Lee, Jane C.

AU - Smith, Stewart B.

AU - Watada, Hirotaka

AU - Lin, Joseph

AU - Scheel, David

AU - Wang, Juehu

AU - Mirmira, Raghu

AU - German, Michael S.

PY - 2001

Y1 - 2001

N2 - Neurogenin3 (ngn3), a basic helix-loop-helix (bHLH) transcription factor, functions as a pro-endocrine factor in the developing pancreas: by itself, it is sufficient to force undifferentiated pancreatic epithelial cells to become islet cells. Because ngn3 expression determines which precursor cells will differentiate into islet cells, the signals that regulate ngn3 expression control islet cell formation. To investigate the factors that control ngn3 gene expression, we mapped the human and mouse ngn3 promoters and delineated transcriptionally active sequences within the human promoter. Surprisingly, the human ngn3 promoter drives transcription in all cell lines tested, including fibroblast cell lines. In contrast, in transgenic animals the promoter drives expression specifically in regions of ngn3 expression in the developing pancreas and gut; and the addition of distal sequences greatly enhances transgene expression. Within the distal enhancer, binding sites for several pancreatic transcription factors, including hepatocyte nuclear factor (HNF)-1 and HNF-3, form a tight cluster. HES1, an inhibitory bHLH factor activated by Notch signaling, binds to the proximal promoter and specifically blocks promoter activity. Together with previous genetic data, these results suggest a model in which the ngn3 gene is activated by the coordinated activities of several pancreatic transcription factors and inhibited by Notch signaling through HES1.

AB - Neurogenin3 (ngn3), a basic helix-loop-helix (bHLH) transcription factor, functions as a pro-endocrine factor in the developing pancreas: by itself, it is sufficient to force undifferentiated pancreatic epithelial cells to become islet cells. Because ngn3 expression determines which precursor cells will differentiate into islet cells, the signals that regulate ngn3 expression control islet cell formation. To investigate the factors that control ngn3 gene expression, we mapped the human and mouse ngn3 promoters and delineated transcriptionally active sequences within the human promoter. Surprisingly, the human ngn3 promoter drives transcription in all cell lines tested, including fibroblast cell lines. In contrast, in transgenic animals the promoter drives expression specifically in regions of ngn3 expression in the developing pancreas and gut; and the addition of distal sequences greatly enhances transgene expression. Within the distal enhancer, binding sites for several pancreatic transcription factors, including hepatocyte nuclear factor (HNF)-1 and HNF-3, form a tight cluster. HES1, an inhibitory bHLH factor activated by Notch signaling, binds to the proximal promoter and specifically blocks promoter activity. Together with previous genetic data, these results suggest a model in which the ngn3 gene is activated by the coordinated activities of several pancreatic transcription factors and inhibited by Notch signaling through HES1.

UR - http://www.scopus.com/inward/record.url?scp=0035029838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035029838&partnerID=8YFLogxK

M3 - Article

C2 - 11334435

AN - SCOPUS:0035029838

VL - 50

SP - 928

EP - 936

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -